Vivasolis had developed the "Don‧Buvanni Customized Cheese" for the public especially those who live with chronic diseases. (Read More)
Monoclonal antibody VSB16 Step to a New Preclinical Stage. (Read More)
October 2017, Vivasolis has been co-owned a patent with Acamedia based on the achivement of industry-university cooperative research since June 2016. (Read More)
